Lacosamide 68462-0697-30
- Manufacturer
- Glenmark Pharmaceuticals Inc., Usa
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 16, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA220268
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
68462-0697-30Selected10 VIAL in 1 CARTON (68462-697-30) / 20 mL in 1 VIAL (68462-697-20)